Table 1

Histolopathogical and molecular characteristics of cancer in a cohort of 231 Saudi breast cancer patients

Histologic type

LUMA No.(%)

LUMB No(%)

HER2 No(%)

Basal No(%)

Hybrid No(%)

UC N0(%)

Total No(%)

IDC

6 (3.3)

27 (14.8)

29 (15.8)

20 (10.9)

16 (8.7)

85 (46.4)

183 (79.2)

ILC

3 (33.3)

5 (55.6)

0 (0)

0 (0)

0 (0)

1 (11.1)

9 (3.89)

ISC

0 (0)

3 (20.)

7 (46.7)

0 (0)

3 (20)

2 (13.3)

15 (6.49)

other*

0 (0)

2 (8.3)

4 (16.7)

3 (12.5)

4 (16.7)

11(45.8)

24 (10.38)

IDC = Invasive ductal carcinoma-NOS, ILC = Invasive lobular carcinoma, ISC = In situ carcinoma, LUMA = luminal A, LUMB = luminal B, HER2 = human epidermal growth factor receptor 2, UC = unclassified

*Include medullary carcinoma, mixed ductal and lobular carcinoma, metaplastic carcinoma, apocrine carcinoma and juvenile secretory carcinoma

Shawarby et al. Diagnostic Pathology 2011 6:57   doi:10.1186/1746-1596-6-57